RxDoctor Payments Data

Sherry Howard

Family · Huber Heights, OHNPI 1679206981

Payments from drug & device makers

$8,735in general payments, 2019–2025

Across 499 payments — averaging $17.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • AbbVie$1K
  • Dexcom, Inc.$899
  • GSK$649
  • Novo Nordisk$500
  • Pfizer$355
  • plus $4K from 37 others

What the payments were for

  • Food & beverage$8,64199%
  • Education$941%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,735 in reported general payments places this provider in the 95th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$33,629
Medicare patients
137
Services billed
752

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide62$65,396
EliquisApixaban51$46,568
TrulicityDulaglutide33$42,755
VraylarCariprazine Hcl27$37,984
MounjaroTirzepatide34$35,426
FarxigaDapagliflozin Propanediol38$32,603
RybelsusSemaglutide24$26,533
LinzessLinaclotide18$20,957
RexultiBrexpiprazole12$17,756
JanuviaSitagliptin Phosphate12$14,117
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$13,374
JardianceEmpagliflozin17$10,485
Aripiprazole22$7,547
NamzaricMemantine Hcl/Donepezil Hcl11$7,003
Levothyroxine Sodium405$4,505

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$500$91,93086 claims
Lilly USA, LLCTrulicity, Mounjaro, Olanzapine$345$80,507118 claims
AbbVieVraylar, Linzess, Namzaric$1,159$65,94456 claims
PfizerEliquis$355$46,56851 claims
AstraZenecaFarxiga, Symbicort$1,509$36,06651 claims
Otsuka America Pharmaceutical, Inc.Rexulti$282$17,75612 claims
MerckJanuvia$31$14,11712 claims
GSKTrelegy Ellipta$649$13,37419 claims
Boehringer IngelheimJardiance$136$10,48517 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$17$4,505405 claims
Almatica Pharma LLCSertraline Hcl$110$1,973224 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,812 family providers in Ohio.

Other family in Huber Heights

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →